Diego Mannhart retweeted
What is the pacing burden in patients receiving PM Tx for LBBB after TAVR based on an HV interval > 55 ms?
Overall 3%, but 41% > 5% at 21 months FU.
Find out more here:
onlinelibrary.wiley.com/doi/…
Great work by @TeodorSerban95 @senfff @swissCTO @thomas_nest @CRIBasel #EPeeps
Diego Mannhart retweeted
BMP 10 - the new kid on the block in AF patients.
Great work by @ElisaHennings
BMP10 - a novel biomarker to predict #MACE and mortality in #atrial #fibrillation patients. #AHAJournals ahajrnls.org/40DQs0d
Diego Mannhart retweeted
Which smartwatch is best for my patient? Our Basel Wearable Study is now published in @JACCJournals
👉🏻Find out more:
sciencedirect.com/science/ar…
#EPeeps @EPeeps_Bot @CRIBasel #Apple #Fitbit #Samsung #Kardia #AliveCor #Withings
Diego Mannhart retweeted
🚨Latest #FreeRead in
@JICE_EP
Research letter: Sex-specific Differences in HV Interval in a Large Cohort of Patients
by T Serban @senfff J. du Fay de Lavallaz, M Kühne @BadertscherPat
📖 #FreeRead: rdcu.be/c0q8s
#EPeeps
@EPeeps_Bot
Diego Mannhart retweeted
Using a Smartwatch for Detection of Loss of Left Ventricular Capture in Patients with Cardiac Resynchronization Therapy heartrhythmjournal.com/artic…
Take a look at our latest work on one of the possible implementation of smart-watches as a diagnostic tool.
What is the use of smartwatches beyond AF detection? Are you able to detect loss of LV Capture in BiV patients using a Smartwatch? Check out our new paper in @hrs_journal @EPeeps_Bot @EpBasel @CRIBasel @Manndie_ #EPeeps
1









